A. Weiss

发表

The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTium.

K. Pajtler, A. Ferrari, S. Spunt, 2022, European journal of cancer.

Desmoid Tumor in Children and Adolescents: The Influence of Age

A. Montag, S. Skapek, A. Weiss, 2012 .

Proceedings of the tumor board of St. Jude Children's Research Hospital, Memphis, Tennessee: Gestational choriocarcinoma

S. Spunt, J. Khoury, S. Kaste, 2006, Pediatric blood & cancer.

Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging Strategies.

D. Freyer, Craig R. Nichols, A. Weiss, 2015, Seminars in oncology.

Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321.

D. Reinke, R. Riedel, R. Randall, 2021, Journal of adolescent and young adult oncology.

Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

S. Knudsen, Martha Donoghue, G. Vassal, 2022, European journal of cancer.

The effects of pazopanib on doxorubicin pharmacokinetics in children and adults with non-rhabdomyosarcoma soft tissue sarcoma: a report from Children’s Oncology Group and NRG Oncology study ARST1321

J. Panetta, S. Baker, T. Scharschmidt, 2022, Cancer Chemotherapy and Pharmacology.

The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors

F. Navid, A. Weiss, David P. Douglass, 2022, Pediatric Drugs.

Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children’s Oncology Group (COG) and the European paediatric soft tissue Sarcoma Study Group (EpSSG) prospective clinical trials

A. Ferrari, S. Spunt, D. Hawkins, 2020 .

An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials

S. Donaldson, D. Rodeberg, D. Hawkins, 2022, Pediatric blood & cancer.

Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).

T. Lipp, E. Thiel, A. Ganser, 2000, Hematology/oncology clinics of North America.

Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding.

M. Masterson, A. Siu, A. Weiss, 2012, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

Clinical trial enrollment of adolescents and young adults with sarcoma

D. Reinke, G. Schwartz, R. Randall, 2017, Cancer.

Social vulnerability as a risk factor for death due to severe paediatric COVID-19

S. Spunt, A. Weiss, 2021 .

Next Generation Sequencing Reveals Skewing of the T and B Cell Receptor Repertoires in Patients with Wiskott–Aldrich Syndrome

L. Notarangelo, K. Dobbs, S. Pai, 2014, Front. Immunol..

Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

J. Healey, D. West, J. Dormans, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Telangiectatic osteosarcoma: The St. Jude Children's Research Hospital's experience

N. Daw, F. Hoffer, Jianrong Wu, 2007, Cancer.

Pediatric Hodgkin lymphoma: Past, present and future

R. Drachtman, A. Weiss, M. Neier, 2009 .

Successful implementation of an international desmoid tumor virtual tumor board: A novel platform for the management of rare tumors

P. Dileo, A. Weiss, Marlene Portnoy, 2020, Rare tumors.

Advances in Therapy for Pediatric Sarcomas

D. Reed, R. Venkatramani, H. Spraker-Perlman, 2014, Current Oncology Reports.

Imaging recommendations for the management of pediatric non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): consensus statement of the International Soft Tissue Sarcoma Consortium (INSTRuCT)

A. Ferrari, C. Morosi, M. B. McCarville, 2023, EJC Paediatric Oncology.

Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group

S. Donaldson, D. Rodeberg, D. Hawkins, 2022, Pediatric blood & cancer.

Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.

Jessica L. Davis, M. Rosen, R. Randall, 2020, The Lancet. Oncology.

Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.

R. Randall, A. Ferrari, S. Spunt, 2019, European journal of cancer.

The significance of margins in pediatric Non‐Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)

K. Pajtler, A. Ferrari, S. Spunt, 2023, Cancer medicine.

Clear cell sarcoma of the gastrointestinal tract presenting as a second malignant neoplasm following neuroblastoma in infancy

S. Saad, A. Weiss, S. Govil, 2012, Pediatric blood & cancer.

An unusual presentation of May-Thurner syndrome in a pediatric patient with a pelvic kidney.

A. Weiss, L. Michaels, J. Eng, 2013, Journal of pediatric urology.

Controversies and challenges in the management of paediatric non-rhabdomyosarcoma soft tissue sarcomas.

K. Pajtler, A. Ferrari, S. Spunt, 2022, The Lancet. Child & adolescent health.

Lymph node metastases in paediatric and young adult patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): Findings from Children's Oncology Group (COG) study ARST0332.

S. Spunt, D. Parham, D. Barkauskas, 2022, European journal of cancer.

Paediatric non-rhabdomyosarcoma soft tissue sarcomas: towards global collaboration.

S. Spunt, A. Weiss, 2021, The Lancet. Child & adolescent health.

Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

James R. Anderson, D. Rodeberg, S. Spunt, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pediatric May‐Thurner Syndrome—Systematic review and individual patient data meta‐analysis

L. Brandão, D. Warad, V. Rodriguez, 2021, Journal of thrombosis and haemostasis : JTH.

Inclusion of Adolescents and Young Adults in Cancer Clinical Trials.

W. Stock, B. Hayes-Lattin, K. Stegenga, 2015, Seminars in oncology nursing.

Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology

S. Spunt, D. Hawkins, S. Terezakis, 2023, Journal of surgical oncology.

Polyuria associated with high-dose methotrexate in two patients with acute lymphoblastic leukaemia

Deborah P. Jones, K. Lau, A. Weiss, 2005, Journal of Oncology Pharmacy Practice.

Outcomes following preoperative chemoradiation +/- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology.

Jessica L. Davis, R. Randall, S. Spunt, 2022, Journal of Clinical Oncology.

Results of the dose-finding phase of ARST 1321 from the Children's Oncology Group and NRG Oncology: Neoadjuvant chemoradiation or radiation therapy +/- pazopanib in non-rhabdomyosarcoma soft tissue sarcomas.

R. Randall, S. Spunt, D. Hawkins, 2019, Journal of Clinical Oncology.

Trimodality Treatment of Extremity Soft Tissue Sarcoma: Where Do We Go Now?

Yen-Lin E Chen, S. Oberoi, E. Choy, 2023, Current Treatment Options in Oncology.

Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology

S. Parsons, D. Reed, N. Mittal, 2023, Pediatric blood & cancer.

INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) consensus statement: Imaging recommendations for the management of rhabdomyosarcoma.

A. Ferrari, C. Morosi, B. Shulkin, 2023, European journal of radiology.

Desmoid tumours in children: when wait-and-see becomes wait-and-treat.

D. Hawkins, A. Weiss, 2017, The Lancet. Child & adolescent health.

Children's Oncology Group's 2023 blueprint for research: Soft tissue sarcomas

E. Rudzinski, S. Wolden, R. Venkatramani, 2023, Pediatric blood & cancer.

ARST1321: Pazopanib neoadjuvant trial in non-rhabdomysarcoma soft tissue sarcomas: A report of major wound complications.

R. Randall, D. Hawkins, Yen-Lin E Chen, 2019, Journal of Clinical Oncology.

Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.

J. Healey, P. Grohar, A. Buxton, 2023, Journal of Clinical Oncology.

Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

J. Healey, D. West, J. Dormans, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Soft Tissue Sarcomas in Adolescents and Young Adults.

D. Harrison, A. Weiss, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.